EA202092820A1 - Композиция для расслабления мышц - Google Patents

Композиция для расслабления мышц

Info

Publication number
EA202092820A1
EA202092820A1 EA202092820A EA202092820A EA202092820A1 EA 202092820 A1 EA202092820 A1 EA 202092820A1 EA 202092820 A EA202092820 A EA 202092820A EA 202092820 A EA202092820 A EA 202092820A EA 202092820 A1 EA202092820 A1 EA 202092820A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptide
muscle relaxation
present
skin wrinkles
sebum production
Prior art date
Application number
EA202092820A
Other languages
English (en)
Inventor
Йонг Джи Чунг
Эюн Ми Ким
Эюнг Джи Ли
Original Assignee
Кареджен Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кареджен Ко., Лтд. filed Critical Кареджен Ко., Лтд.
Priority claimed from PCT/KR2019/013916 external-priority patent/WO2020138674A1/ko
Publication of EA202092820A1 publication Critical patent/EA202092820A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Rigid Containers With Two Or More Constituent Elements (AREA)
  • Laminated Bodies (AREA)

Abstract

Настоящее изобретение относится к пептиду, проявляющему физиологическую активность, и к композиции, содержащей тот же пептид. Пептид по настоящему изобретению проявляет различные физиологические активности, такие как расслабление мышц, уменьшение морщин на коже, ингибирование образования кожного сала и т.п. Подобный пептид как таковой можно использовать в качестве активного ингредиента в фармацевтической композиции для расслабления мышц или в косметическом средстве для уменьшения морщин кожи, ингибирования образования кожного сала или уменьшения угрей.
EA202092820A 2018-12-26 2019-10-22 Композиция для расслабления мышц EA202092820A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180169495 2018-12-26
KR1020190083008A KR102132274B1 (ko) 2018-12-26 2019-07-10 근육 이완용 조성물
PCT/KR2019/013916 WO2020138674A1 (ko) 2018-12-26 2019-10-22 근육 이완용 조성물

Publications (1)

Publication Number Publication Date
EA202092820A1 true EA202092820A1 (ru) 2021-02-09

Family

ID=71571557

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092820A EA202092820A1 (ru) 2018-12-26 2019-10-22 Композиция для расслабления мышц

Country Status (15)

Country Link
US (1) US11306121B2 (ru)
EP (1) EP3815674A4 (ru)
JP (1) JP7110405B2 (ru)
KR (1) KR102132274B1 (ru)
CN (1) CN112367967B (ru)
AR (1) AR117730A1 (ru)
BR (1) BR112020026825A2 (ru)
CA (1) CA3103204C (ru)
EA (1) EA202092820A1 (ru)
IL (1) IL279386A (ru)
MX (1) MX2020014330A (ru)
PH (1) PH12020552142A1 (ru)
SG (1) SG11202100812UA (ru)
TW (1) TWI730562B (ru)
UA (1) UA125331C2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115916236A (zh) * 2020-06-12 2023-04-04 凯尔格恩有限公司 包含五肽作为活性成分的组合物
KR102463320B1 (ko) * 2020-06-12 2022-11-07 (주)케어젠 펜타펩타이드를 유효성분으로 포함하는 통증의 완화, 예방 또는 치료용 조성물
CN114560912B (zh) * 2022-03-28 2023-10-20 碧悦星泽(北京)生物医药科技有限公司 一种具有抗皱功能的多肽及其复合物与应用
KR20230170490A (ko) * 2022-06-10 2023-12-19 (주)케어젠 근육 손실 저해 및 근육량 증진 활성을 갖는 펩타이드 및 이의 용도
KR20240086947A (ko) * 2022-12-09 2024-06-19 (주)케어젠 연골 재생용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160485B1 (es) 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
CN101720331A (zh) 2007-06-01 2010-06-02 德国麦氏大药厂 基于肉毒毒素的神经毒成分供应温度-稳定性肌肉松弛剂的方法
CA2970108C (en) * 2007-06-27 2020-04-07 The Board Of Trustees Of The Leland Stanford Junior University Oligopeptide tyrosinase inhibitors and uses thereof
EP3192808A1 (en) 2007-11-27 2017-07-19 The University Of British Columbia 14-3-3 antagonists for the prevention and treatment of arthritis
GB201319620D0 (en) * 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) * 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy

Also Published As

Publication number Publication date
AR117730A1 (es) 2021-08-25
BR112020026825A2 (pt) 2021-07-27
CA3103204A1 (en) 2020-07-02
JP7110405B2 (ja) 2022-08-01
US11306121B2 (en) 2022-04-19
MX2020014330A (es) 2021-03-09
CN112367967B (zh) 2023-04-04
PH12020552142A1 (en) 2021-06-28
KR20200080108A (ko) 2020-07-06
EP3815674A1 (en) 2021-05-05
TWI730562B (zh) 2021-06-11
EP3815674A4 (en) 2021-08-04
UA125331C2 (uk) 2022-02-16
TW202024116A (zh) 2020-07-01
KR102132274B1 (ko) 2020-07-09
SG11202100812UA (en) 2021-02-25
JP2021526154A (ja) 2021-09-30
US20210246165A1 (en) 2021-08-12
CN112367967A (zh) 2021-02-12
CA3103204C (en) 2023-08-01
IL279386A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
EA202092820A1 (ru) Композиция для расслабления мышц
PH12017502092A1 (en) Topical pharmaceutical compositions
MX337830B (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
WO2017155232A3 (ko) 발모 촉진 활성 및/또는 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
MX2015010185A (es) Composicion para uso cosmetico adecuada para producir un efecto de pigmentacion sobre el cabello.
WO2017164609A3 (ko) 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
EP4349361A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
EA202190888A1 (ru) Пептид для применения в косметике
MX2016016400A (es) Formulaciones de oximetazolina estabilizadas y sus usos.
PH12020500055A1 (en) A personal care composition
MX2021012353A (es) Composicion cosmetica topica y usos de la misma.
EA202092077A1 (ru) Местные составы, содержащие стронций и метилсульфонилметан (мсм), и способы лечения
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
WO2013087665A3 (en) Composition comprising a carboxylated fructan for epidermis hydratation
MX2021008812A (es) Composicion cosmetica/dermatologica.
MX2020001764A (es) Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello.
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
MX2019014426A (es) Composicion farmaceutica para usarse en la mejora de la calidad del cuero cabelludo y la piel, de la cicatrizacion de heridas o mejora de la calidad del cabello.
EA201800177A1 (ru) Применение бактериородопсина в качестве косметического и/или лечебного средства при комплексном лечении дерматозов
RU2010127390A (ru) Способ лечения облысения
WO2017205779A3 (en) Compositions and methods for treating disorders related to inflammasome activity and il-1alpha expression
SG10201706771XA (en) Skin protection and anti-itching formulation